This document discusses using Internet of Medical Things (IoMT) technologies to help address challenges with COVID-19 diagnosis and management. It outlines problems with current COVID-19 testing methods like long wait times, high costs, and limited availability. Point-of-care technologies like lateral flow immunoassays could provide faster, cheaper, and more accessible testing. The document then introduces IoMT as an extension of IoT for healthcare that uses connected medical devices and data sharing to provide disease monitoring and analysis. It proposes applying IoMT through services like patient tracking, data sharing, and information gathering to help with COVID-19 response and outlines some technical challenges still to address like security and routing protocols.